Fast-onset energy and focus
Dynamine® produces noticeable energy, mental clarity, and focus within 15–30 minutes — faster than caffeine (30–60 min) and much faster than TeaCrine® (45–90 min). This rapid onset makes it ideal as an immediate pre-workout primer or acute cognitive booster, filling the gap before caffeine reaches peak plasma concentration.
No cardiovascular side effects
Unlike caffeine, Dynamine® does not significantly elevate heart rate or blood pressure at clinical doses (100–200 mg). Safety studies confirm no adverse hemodynamic effects — enabling use by caffeine-sensitive individuals and those who want mental energy benefits without cardiovascular stimulation.
Caffeine synergy and half-life extension
A landmark pharmacokinetic study confirmed Dynamine® extends caffeine's half-life approximately 2-fold and increases caffeine's area under the curve — meaning caffeine stays active longer and at higher concentrations when combined with Dynamine®. This allows lower caffeine doses to deliver stronger, more sustained effects, reducing caffeine-related side effects while improving performance.
Mood elevation and motivation
Dynamine® modulates dopaminergic signaling pathways, producing mood elevation, motivation enhancement, and feelings of well-being. Combined with adenosine receptor antagonism, this produces a motivational state that enhances both physical training and cognitive work performance without the anxiety associated with high-dose caffeine.
Adenosine receptor antagonism and dopamine modulation
Methylliberine blocks adenosine A1 and A2A receptors — the same primary mechanism as caffeine — preventing adenosine-driven fatigue signaling and maintaining dopaminergic tone. Unlike caffeine, methylliberine appears to have greater selectivity for dopamine D2 receptor modulation, contributing to its mood-enhancing and motivational effects without the anxiogenic side effects mediated by adenosine A2A blockade in amygdala circuits.
Randomized, double-blind, placebo-controlled safety study of methylliberine (Dynamine®) alone and in combination with TeaCrine® in healthy young adults. Published in Nutrients.
Healthy young adults. Published in Nutrients (PMC7146520).
Dynamine® alone and in combination with TeaCrine® showed no adverse effects on heart rate, blood pressure, ECG parameters, or clinical blood markers. Subjective energy and focus significantly improved vs. placebo. Safety profile confirmed at doses up to 300 mg. No cardiovascular stimulation observed.
Pharmacokinetic study examining the interaction between Dynamine® and caffeine in vivo.
Healthy adults. Pharmacokinetic crossover design.
Dynamine® extended caffeine's half-life approximately 2-fold and increased caffeine AUC (area under the curve) significantly. Adding TeaCrine® to the stack extended effects further. Supports Dynamine® as a caffeine potentiator enabling lower effective caffeine doses.